Pascal Chanez

46.2k total citations · 10 hit papers
447 papers, 25.6k citations indexed

About

Pascal Chanez is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Pascal Chanez has authored 447 papers receiving a total of 25.6k indexed citations (citations by other indexed papers that have themselves been cited), including 315 papers in Physiology, 237 papers in Pulmonary and Respiratory Medicine and 72 papers in Immunology. Recurrent topics in Pascal Chanez's work include Asthma and respiratory diseases (303 papers), Respiratory and Cough-Related Research (125 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (92 papers). Pascal Chanez is often cited by papers focused on Asthma and respiratory diseases (303 papers), Respiratory and Cough-Related Research (125 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (92 papers). Pascal Chanez collaborates with scholars based in France, United States and United Kingdom. Pascal Chanez's co-authors include Jean Bousquet, Philippe Godard, Isabelle Vachier, Ian Pavord, Héctor Ortega, Oliver N. Keene, Eugene R. Bleecker, Peter Howarth, I. Enander and Stephanie Korn and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Pascal Chanez

424 papers receiving 24.8k citations

Hit Papers

Eosinophilic Inflammation... 1990 2026 2002 2014 1990 2014 2012 2016 1993 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Eosinophilic Inflammation in Asthma
    1990 2.1k citations Jean Bousquet, Pascal Chanez et al. profile →
  2. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    2014 1.6k citations Ian Pavord, Guy Brusselle et al. profile →
  3. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
    2012 1.6k citations Ian Pavord, Stephanie Korn et al. profile →
  4. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
    2016 976 citations Pascal Chanez, Alberto Papi et al. profile →
  5. Induction of nitric oxide synthase in asthma
    1993 700 citations Pascal Chanez, Jean Bousquet et al. profile →
  6. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells
    2015 434 citations Martijn J. Schuijs, Monique Willart et al. Science profile →
  7. Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
    2014 406 citations Pascal Chanez et al. profile →
  8. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
    2017 384 citations Ian Pavord, Pascal Chanez et al. profile →
  9. Eosinophils in Health and Disease: A State-of-the-Art Review
    2021 164 citations Michael E. Wechsler, Ariel Munitz et al. Mayo Clinic Proceedings profile →
  10. Airway remodelling in asthma and the epithelium: on the edge of a new era
    2024 44 citations Bart N. Lambrecht, Pascal Chanez et al. European Respiratory Journal profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pascal Chanez 18.7k 14.6k 5.1k 4.5k 3.0k 447 25.6k
Eugene R. Bleecker 19.7k 1.1× 14.7k 1.0× 5.0k 1.0× 3.3k 0.7× 2.8k 0.9× 332 25.3k
Christopher E. Brightling 21.1k 1.1× 17.3k 1.2× 7.0k 1.4× 3.6k 0.8× 3.1k 1.0× 496 29.1k
Andrew J. Wardlaw 19.5k 1.0× 12.5k 0.9× 8.3k 1.6× 5.7k 1.3× 3.5k 1.2× 267 27.2k
Paul M. O’Byrne 30.4k 1.6× 22.7k 1.6× 6.6k 1.3× 7.6k 1.7× 3.1k 1.0× 556 38.1k
Ian Pavord 28.4k 1.5× 24.6k 1.7× 6.0k 1.2× 4.3k 0.9× 4.1k 1.4× 608 35.3k
Sally E. Wenzel 27.6k 1.5× 18.8k 1.3× 9.3k 1.8× 6.3k 1.4× 4.3k 1.5× 370 34.8k
Guy Brusselle 12.1k 0.6× 12.5k 0.9× 4.3k 0.8× 2.5k 0.5× 2.2k 0.7× 445 22.8k
Ratko Djukanović 12.0k 0.6× 8.1k 0.6× 5.0k 1.0× 3.5k 0.8× 1.5k 0.5× 239 17.0k
Peter Bradding 11.8k 0.6× 7.1k 0.5× 6.8k 1.3× 3.6k 0.8× 1.8k 0.6× 265 17.1k
John V. Fahy 11.6k 0.6× 8.5k 0.6× 4.8k 0.9× 2.7k 0.6× 1.9k 0.6× 142 17.4k

Countries citing papers authored by Pascal Chanez

Since Specialization
Citations

This map shows the geographic impact of Pascal Chanez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Chanez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Chanez more than expected).

Fields of papers citing papers by Pascal Chanez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Chanez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Chanez. The network helps show where Pascal Chanez may publish in the future.

Co-authorship network of co-authors of Pascal Chanez

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Chanez. A scholar is included among the top collaborators of Pascal Chanez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Chanez. Pascal Chanez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jackson, David J., Njira Lugogo, Mark Gurnell, et al.. (2025). Tezepelumab Reduces and Eliminates OCS Use in OCS-Dependent Patients With Severe Asthma: Primary Results from the Phase 3b WAYFINDER Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5231–A5231. 1 indexed citations
3.
Bourdin, Arnaud, et al.. (2024). EFFICACY OF BENRALIZUMAB AND MEPOLIZUMAB ON ASTHMA OUTCOMES IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS. Annals of Allergy Asthma & Immunology. 133(6). S49–S50. 1 indexed citations
4.
Tarantini, Adeline, Carey Suehs, Erika Nogué, et al.. (2024). Occupational exposure to aerosols in two French airports: multi-year lung function changes. Annals of Work Exposures and Health. 69(1). 17–33. 1 indexed citations
5.
Assou, Saïd, Véronique Pantesco, Catherine Duez, et al.. (2022). Platelets Purification Is a Crucial Step for Transcriptomic Analysis. International Journal of Molecular Sciences. 23(6). 3100–3100. 9 indexed citations
6.
Suehs, Carey, Khuder Alagha, Arnaud Bourdin, et al.. (2021). Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study. Therapeutic Advances in Respiratory Disease. 15. 2663629063–2663629063. 2 indexed citations
7.
Wechsler, Michael E., Ariel Munitz, Steven J. Ackerman, et al.. (2021). Eosinophils in Health and Disease: A State-of-the-Art Review. Mayo Clinic Proceedings. 96(10). 2694–2707. 164 indexed citations breakdown →
8.
Loiseau, Étienne, Simon Gsell, Delphine Gras, et al.. (2020). Active mucus–cilia hydrodynamic coupling drives self-organization of human bronchial epithelium. Nature Physics. 16(11). 1158–1164. 40 indexed citations
9.
Persson, Emma K., Kenneth Verstraete, Ines Heyndrickx, et al.. (2019). Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. Science. 364(6442). 207 indexed citations
10.
Chanez, Pascal, Lisa Hickey, Margaret Garin, & Mario Castro. (2019). Evaluation of Eosinophilic Asthma Patients Without Blood Eosinophil (EOS) Response to Intravenous (IV) Reslizumab in a Post-Hoc Analysis of 52-Week Placebo-Controlled Phase 3 Studies. Journal of Allergy and Clinical Immunology. 143(2). AB97–AB97. 2 indexed citations
11.
Schuijs, Martijn J., Monique Willart, Karl Vergote, et al.. (2015). Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science. 349(6252). 1106–1110. 434 indexed citations breakdown →
12.
Papi, Alberto, Pascal Chanez, Maciej Kupczyk, et al.. (2014). Frequent exacerbators - a distinct phenotype of severe asthma. Homo Politicus (Academy of Humanities and Economics in Lodz). 116 indexed citations
13.
Tomasini, Pascale, et al.. (2013). Solitary cystic mediastinal lymphangioma. European Respiratory Review. 22(127). 91–93. 13 indexed citations
14.
Holgate, Stephen T., Michael Noonan, Pascal Chanez, et al.. (2010). Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial. European Respiratory Journal. 37(6). 1352–1359. 134 indexed citations
15.
Burgel, Pierre‐Régis, D. Caillaud, Isabelle Tillie‐Leblond, et al.. (2010). Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. European Respiratory Journal. 36(3). 531–539. 240 indexed citations
16.
Gagliardo, Rosalia, Pascal Chanez, Marc Mathieu, et al.. (2003). Persistent Activation of Nuclear Factor–κB Signaling Pathway in Severe Uncontrolled Asthma. American Journal of Respiratory and Critical Care Medicine. 168(10). 1190–1198. 134 indexed citations
17.
18.
Marchand, Éric, et al.. (2003). Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?. European Respiratory Journal. 22(1). 8–13. 78 indexed citations
19.
Bonnans, Caroline, et al.. (2003). Glucocorticoid receptor-binding characteristics in severe asthma. European Respiratory Journal. 21(6). 985–988. 13 indexed citations
20.
Chanez, Pascal, et al.. (1992). Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. Journal of Allergy and Clinical Immunology. 90(2). 215–224. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugene R. Bleecker Breakdown of academic impact, for papers by Christopher E. Brightling Breakdown of academic impact, for papers by Andrew J. Wardlaw Breakdown of academic impact, for papers by Paul M. O’Byrne Breakdown of academic impact, for papers by Ian Pavord Breakdown of academic impact, for papers by Sally E. Wenzel Breakdown of academic impact, for papers by Guy Brusselle Breakdown of academic impact, for papers by Ratko Djukanović Breakdown of academic impact, for papers by Peter Bradding Breakdown of academic impact, for papers by John V. Fahy
Rankless by CCL
2026